Pessary Experience Study
Longitudinal Assessment of Pessary Experience
1 other identifier
observational
30
1 country
1
Brief Summary
Pessaries are silicone devices inserted into the vagina for treatment of pelvic organ prolapse or stress urinary incontinence. They are adequate treatment options for patients who are poor surgical candidates, those who decline surgical intervention, or as a temporizing measure in those ultimately planning surgery. Most studies suggest that about 75% of patients are able to be successfully fit with a pessary, but about 50% discontinue pessary use within 12 months of initiation. The purpose of this study is to determine why pessaries are discontinued.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jun 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 12, 2023
CompletedFirst Submitted
Initial submission to the registry
August 26, 2023
CompletedFirst Posted
Study publicly available on registry
September 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
ExpectedJanuary 28, 2025
January 1, 2025
2.5 years
August 26, 2023
January 26, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Qualitative analysis
Perform a patient-centered, qualitative analysis of pessary discontinuation
up to 1 year after pessary fitting
Pelvic Floor symptom improvement as related to quality of life
Assess changes in pelvic floor symptoms and quality of life before and after pessary use as measured by validated questionnaires
up to 1 year after pessary fitting
Discontinuation of pessaries
Rates of discontinuation at 1 year
up to 1 year after pessary fitting
Why do women discontinue using pessaries?
Factors significantly associated with discontinuation
up to 1 year after pessary fitting
Study Arms (1)
Women being fitted with pessaries
Women being fitted with pessaries as standard of care will be eligible to participate. They will be asked to complete a recorded verbal interview and written questionnaires the day they have their pessaries fitted and at their follow-up clinic appointments at 4-6 weeks, 3 months, 6 months, and 12 months. Another recorded video interview will be completed at the 12 month appointment.
Interventions
Eligibility Criteria
Women in the area surrounding the University of Virginia who have stress urinary incontinences or pelvic organ prolapse.
You may qualify if:
- English-speaking women aged 18 years or older
- Choosing to undergo a pessary fitting for symptomatic pelvic organ prolapse and/or stress urinary incontinence at the University of Virginia Pelvic Medicine and Reconstructive Surgery clinic
- Willingness and ability to comply with scheduled visits and study procedures.
- Successful pessary fitting
You may not qualify if:
- Pregnant women
- Prisoners
- Cognitively impaired
- Non-English speaking subjects
- Patients who cannot comply with pessary check visits
- Active vaginal infection
- Vaginal malignancy
- Genitourinary tract fistula
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Virginia
Charlottesville, Virginia, 22903, United States
Related Publications (3)
Yimphong T, Temtanakitpaisan T, Buppasiri P, Chongsomchai C, Kanchaiyaphum S. Discontinuation rate and adverse events after 1 year of vaginal pessary use in women with pelvic organ prolapse. Int Urogynecol J. 2018 Aug;29(8):1123-1128. doi: 10.1007/s00192-017-3445-x. Epub 2017 Aug 16.
PMID: 28815277BACKGROUNDPanman CM, Wiegersma M, Kollen BJ, Burger H, Berger MY, Dekker JH. Predictors of unsuccessful pessary fitting in women with prolapse: a cross-sectional study in general practice. Int Urogynecol J. 2017 Feb;28(2):307-313. doi: 10.1007/s00192-016-3107-4. Epub 2016 Aug 15.
PMID: 27525693BACKGROUNDUmachanger JK, Marcussen ML, Boggild H, Kjaergaard N, Glavind K. First-line treatment of pelvic organ prolapse and discontinuation of pessary treatment. Int Urogynecol J. 2020 Sep;31(9):1813-1819. doi: 10.1007/s00192-020-04338-w. Epub 2020 May 24.
PMID: 32447418BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Monique Vaughan, MD
Assistant Professor
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
August 26, 2023
First Posted
September 1, 2023
Study Start
June 12, 2023
Primary Completion
December 1, 2025
Study Completion (Estimated)
December 1, 2026
Last Updated
January 28, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share